B iopharmaceutical manufacturing uses living cells to produce therapies that treat diseases like cancer, diabetes, and autoimmune disorders. Manufacturing medicine using biology presents different challenges from the traditional chemical manufacturing processes that stamp out identical pressed pills.
Biomanufacturing processes are hard to control...
In my capacity as the Chair of the Council of the Manufacturing USA institute directors, I often get asked about trends in U.S. advanced manufacturing. When I receive a question like this, I try to think about advanced manufacturing as broadly as possible — and consider technologies that could stand to benefit most manufacturers, as well as the U.S...
The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.
There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the...
The Delaware Biotechnology Institute will expand into 70,000 square feet within the new six-story, $160 million Biopharmaceutical Innovation Building on the STAR Campus next February.
The building, which includes labs, offices, collaborative space, and shared researchinstrumentation facilities, will be the home of the National Institute for...
Sporting white hard hats, bright safety vests and protective goggles, Delaware Gov. John Carney and a small group of officials visited the construction site of the University of Delaware’s Ammon Pinizzotto Biopharmaceutical Innovation Center on Tuesday, Feb. 5. The tour offered a glimpse into the future of growth and innovation at the University.
“...
